In this issue:
Patient blood management guidelines for adults with critical bleeding
Using COVID-19 therapeutics in patients with haematological malignancies
BSH guideline: Managing newly diagnosed LBCL
BSH Good Practice Paper: Diagnosing and managing SMM
Treating BCR/ABL-positive CML in children
Predicting the histology of relapsed or refractory lymphoma using FDG-PET
CAR-T recipients report higher rates of ‘potentially serious’ toxicities
Erwinase (crisantaspase) approved for use
Genetic testing for variants associated with haematological malignancies
PBS update: Ibrutinib (Imbruvica)
New AusPAR for avatrombopag (Doptelet)
New AusPAR for tafasitamab (Minjuvi)
Hypertension treatment in patients receiving ibrutinib
Risk of venous thromboembolic events after surgery for cancer
Death from MCL limits sequential therapy, particularly after first relapse
COVID-19 resources
Conferences, workshops and CPD
Please login below to download this issue (PDF)